Profile data is unavailable for this security.
About the company
IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The Company is also engaged in providing the precision medicine business. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
- Revenue in USD (TTM)0.00
- Net income in USD-5.63m
- Incorporated2018
- Employees2.00
- LocationIMAC Holdings Inc1605 Westgate CirBRENTWOOD 37027United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://imacregeneration.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Health Management Corp. | 483.00k | -25.60m | 470.65k | 56.00 | -- | -- | -- | 0.9744 | -1,378.45 | -1,378.45 | 25.37 | -41.35 | 0.0425 | 1.16 | 1.49 | 8,625.00 | -190.82 | -- | -395.01 | -- | -2,014.49 | -- | -4,486.13 | -- | 0.0203 | -1,353.25 | -- | -- | 37.69 | -- | -363.55 | -- | -- | -- |
| SPO Global Inc | 838.00k | -540.00k | 720.24k | 2.00 | -- | -- | -- | 0.8595 | -85.99 | -85.99 | 131.76 | -476.56 | 1.76 | -- | -- | -- | -113.56 | -305.39 | -- | -- | 31.15 | 27.31 | -64.44 | -384.85 | -- | -1.45 | -- | -- | -17.09 | -15.13 | 13.03 | -- | -- | -- |
| Modern Mobility Aids Inc | 0.00 | -1.59m | 1.37m | -- | -- | -- | -- | -- | -0.0177 | -0.0177 | 0.00 | -0.004 | 0.00 | -- | -- | -- | -4,668.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -371.94 | -- | -- | -- |
| Mitesco Inc | 0.00 | -10.91m | 1.48m | 3.00 | -- | -- | -- | -- | -1.91 | -1.94 | 0.00 | -2.60 | 0.00 | -- | -- | 0.00 | -10,172.81 | -246.54 | -- | -- | -- | -- | -- | -29,214.62 | -- | -0.1207 | -- | -- | -- | -- | -59.12 | -- | -- | -- |
| IMAC Holdings Inc | 0.00 | -5.63m | 1.95m | 2.00 | -- | -- | -- | -- | -5.04 | -5.46 | 0.00 | -1.08 | 0.00 | -- | 0.00 | 0.00 | -166.65 | -48.88 | -1,050.71 | -70.25 | -- | -- | -- | -97.63 | -- | -14.97 | -- | -- | -- | -- | 45.27 | -- | -- | -- |
| avVaa World Health Care Products Inc | 39.74k | 49.55k | 2.13m | 2.00 | 73.33 | -- | 42.91 | 53.50 | 0.00003 | 0.00003 | 0.00002 | -0.0069 | 0.8149 | -- | 9.63 | -- | 101.60 | 2,695.88 | -- | -- | 95.92 | 80.55 | 124.69 | 6,316.05 | -- | -- | -- | 0.00 | 142.40 | -12.09 | 159.21 | -- | -- | -- |
| QHSLab Inc | 1.41m | -468.37k | 2.35m | 4.00 | -- | -- | -- | 1.67 | -0.0499 | -0.0499 | 0.1496 | -0.0386 | 0.7744 | 15.98 | 23.66 | 352,250.00 | -25.74 | -51.17 | -- | -197.31 | 56.32 | -- | -33.24 | -65.10 | 0.0637 | -1.04 | 1.27 | -- | 13.34 | -- | 52.98 | -- | -- | -- |
| Greenbrook TMS Inc | 72.49m | -52.54m | 2.61m | 629.00 | -- | -- | -- | 0.036 | -1.24 | -1.24 | 1.71 | -2.45 | 0.9471 | -- | 6.22 | -- | -69.41 | -68.51 | -113.55 | -106.45 | 25.92 | 38.65 | -73.29 | -76.82 | -- | -2.40 | 136.38 | -- | 10.42 | 28.26 | 44.21 | -- | -54.79 | -- |
| Ethema Health Corp | 5.35m | 957.28k | 2.98m | 65.00 | 3.48 | -- | 2.37 | 0.5581 | 0.0002 | 0.0002 | 0.0014 | -0.0018 | 0.5885 | -- | 11.88 | 82,231.23 | 8.90 | -37.68 | -- | -- | -- | -- | 15.12 | -94.87 | -- | -1.08 | 4.99 | -- | 10.87 | 65.34 | 652.41 | -- | 74.97 | -- |
| CompuMed Inc | 1.78m | -151.00k | 3.69m | 8.00 | -- | 28.33 | -- | 2.07 | -0.1337 | -0.1337 | 1.58 | 0.0997 | 2.38 | 36.71 | 4.83 | -- | -19.92 | -46.77 | -48.38 | -76.78 | 50.42 | 57.04 | -8.38 | -25.84 | 0.9493 | -2.93 | 0.7744 | -- | -1.73 | -5.71 | 64.41 | -- | -18.75 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Kestra Advisory Services LLCas of 31 Mar 2024 | 56.39k | 4.91% |
| HRT Financial LLCas of 31 Mar 2024 | 51.86k | 4.52% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 22.45k | 1.96% |
| Two Sigma Investments LPas of 31 Mar 2024 | 11.38k | 0.99% |
| Tower Research Capital LLCas of 31 Mar 2024 | 6.52k | 0.57% |
| UBS Securities LLCas of 31 Mar 2024 | 230.00 | 0.02% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 167.00 | 0.02% |
| Newbridge Financial Services Group, Inc.as of 31 Mar 2024 | 167.00 | 0.02% |
| Financial Perspectives, Inc.as of 31 Mar 2024 | 20.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 8.00 | 0.00% |
